[Study on potential anti-caries DNA vaccine pcDNA3-gtfB integration into host cell genome].
OBJECTIVE
Gene vaccine security is of concern because of the possibility of insertion mutagenesis resulting in inactivation of tumor suppressor or activation of oncogene. The purpose of this study was to examine the potential of anti-caries DNA vaccine pcDNA3-gtfB integrating into the host cell genome.


METHODS
Anti-caries DNA vaccine pcDNA3-gtfB was constructed by the previous study. The gtfB gene(904-4,578 bp, genebank M17361) was cloned from Streptococcus mutans GS-5. 36 Wistar rats were divided into 2 groups: submandibular gland-targeted injection(SGT) group and control group. Rats in SGT group were injected with 100 micrograms of plasmid pcDNA3-gtfB, rats in control group with PBS solution. Genomes from submandibular gland, kidney, heart, liver, lung, and brain tissues were isolated later in 12 weeks. Genomes from different tissues were purified by low-melting agarose electrophoresis. Using the purified genomes as template, plasmid integration were examined by PCR(upper primer: 5'-ATATGGTACCATGACCGAAGCGACATCTAAGCAAGA-3', lower primer: 5'-ACTACTCGAGTTAGAACCATTGACCCTG AGCATTGC-3'). The sensitivity level of PCR was determined by adding gradient plasmid copies into genomes in control group.


RESULTS
The examination of 6 tissues failed in revealing any evidence of integration at the sensitivity level that could detect 1 copy integration in 10,000 nuclei.


CONCLUSIONS
The potential frequency of plasmid pcDNA3-gtfB integration into host cell genome would not exceed that of the spontaneous mutation. It was indicated that pcDNA3-gtfB was genetically safe as a promising anti-carious DNA vaccine.
Yang
Jinbo
J
Key Lab. for Oral Biomedical Engineering Ministry of Education, West China College of Stomatology, Sichuan University, Chengdu 610041, China.
Liu
Tianjia
T
Li
Jiyao
J
D000818:Animals; D000974:Antibodies, Antinuclear / Q000235:genetics / Q000276:immunology; D003001:Cloning, Molecular; D003731:Dental Caries / Q000517:prevention & control; D005057:Eukaryotic Cells / Q000378:metabolism; D005822:Genetic Vectors; D005964:Glucosyltransferases / Q000235:genetics*; D010957:Plasmids / Q000235:genetics / Q000276:immunology; D051381:Rats; D017208:Rats, Wistar; D011995:Recombination, Genetic; D022541:Streptococcal Vaccines / Q000235:genetics*; D013295:Streptococcus mutans / Q000235:genetics* / Q000276:immunology; D019444:Vaccines, DNA / Q000009:adverse effects / Q000235:genetics* / Q000276:immunology
D000974:Antibodies, Antinuclear; D022541:Streptococcal Vaccines; D019444:Vaccines, DNA; D005964:Glucosyltransferases